Moon et al. [46] showed that an overexpression of MAFF leads to an activation of the signal transducer and activator of transcription 3 (STAT3) pathway, which signals upstream of IL-6, a known biomarker and therapeutic target in SJIA [47]. This evidence concerns the gene STAT3 and systemic-onset juvenile idiopathic arthritis.